A History of the Development of Brucella Vaccines

Overview

Journal Biomed Res Int

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
General Medicine

Date 2013 Jul 18

PMID 23862154

Citations 65

Authors

Eric Daniel Avila-Calderon

Ahide Lopez-Merino

Nammalwar Sriranganathan

Stephen M Boyle

Araceli Contreras-Rodriguez

Affiliations

Soon will be listed here.

Abstract

Brucellosis is a worldwide zoonosis affecting animal and human health. In the last several decades, much research has been performed to develop safer Brucella vaccines to control the disease mainly in animals. Till now, no effective human vaccine is available. The aim of this paper is to review and discuss the importance of methodologies used to develop Brucella vaccines in pursuing this challenge.

Citing Articles

Immunogenic Consideration of a Designed Polypeptide Against Brucellosis Compared to RB51: An Study.

Saadat M, Bandehpour M, Kazemi B, Mosaffa N Avicenna J Med Biotechnol. 2024; 16(4):251-259.

PMID: 39606679 PMC: 11589429. DOI: 10.18502/ajmb.v16i4.16741.

A Thermosensitive and Degradable Chitin-Based Hydrogel as a Brucellosis Vaccine Adjuvant.

Ju R, Lu Y, Jiang Z, Chi J, Wang S, Liu W Polymers (Basel). 2024; 16(19).

PMID: 39408526 PMC: 11478596. DOI: 10.3390/polym16192815.

Investigation of the Seroprevalence of Brucella Antibodies and Characterization of Field Strains in Immunized Dairy Cows by A19.

Shi Y, Cui Y, Wudong G, Li S, Yuan Y, Zhao D Vet Sci. 2024; 11(7).

PMID: 39057972 PMC: 11281660. DOI: 10.3390/vetsci11070288.

A subunit vaccine based on rBP26 induces Th1 immune responses and M1 macrophage activation.

Wen J, Li Z, Lv Y, Ding S, Zhu Y, Yang J Acta Biochim Biophys Sin (Shanghai). 2024; 56(6):879-891.

PMID: 38419498 PMC: 11292127. DOI: 10.3724/abbs.2024023.

One-step preparation of a self-assembled bioconjugate nanovaccine against .

Huang J, Guo Y, Yu S, Wang D, Li S, Wu J Virulence. 2023; 14(1):2280377.

PMID: 37981707 PMC: 10732601. DOI: 10.1080/21505594.2023.2280377.

References

Ariza J, Bosilkovski M, Cascio A, Colmenero J, Corbel M, Falagas M . Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. PLoS Med. 2007; 4(12):e317. PMC: 2222927. DOI: 10.1371/journal.pmed.0040317. View

Yu D, Li M, Hu X, Cai H . A combined DNA vaccine enhances protective immunity against Mycobacterium tuberculosis and Brucella abortus in the presence of an IL-12 expression vector. Vaccine. 2007; 25(37-38):6744-54. DOI: 10.1016/j.vaccine.2007.06.061. View

Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos E . The new global map of human brucellosis. Lancet Infect Dis. 2006; 6(2):91-9. DOI: 10.1016/S1473-3099(06)70382-6. View

Montaraz J, Winter A . Comparison of living and nonliving vaccines for Brucella abortus in BALB/c mice. Infect Immun. 1986; 53(2):245-51. PMC: 260865. DOI: 10.1128/iai.53.2.245-251.1986. View

Pasquevich K, Ibanez A, Coria L, Garcia Samartino C, Estein S, Zwerdling A . An oral vaccine based on U-Omp19 induces protection against B. abortus mucosal challenge by inducing an adaptive IL-17 immune response in mice. PLoS One. 2011; 6(1):e16203. PMC: 3021544. DOI: 10.1371/journal.pone.0016203. View

Al-Mariri A, Tibor A, Mertens P, De Bolle X, Michel P, Godefroid J . Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant. Infect Immun. 2001; 69(8):4816-22. PMC: 98569. DOI: 10.1128/IAI.69.8.4816-4822.2001. View

Boigegrain R, Salhi I, Alvarez-Martinez M, Machold J, Fedon Y, Arpagaus M . Release of periplasmic proteins of Brucella suis upon acidic shock involves the outer membrane protein Omp25. Infect Immun. 2004; 72(10):5693-703. PMC: 517528. DOI: 10.1128/IAI.72.10.5693-5703.2004. View

Gamazo C, Winter A, Moriyon I, Riezu-Boj J, Blasco J, Diaz R . Comparative analyses of proteins extracted by hot saline or released spontaneously into outer membrane blebs from field strains of Brucella ovis and Brucella melitensis. Infect Immun. 1989; 57(5):1419-26. PMC: 313293. DOI: 10.1128/iai.57.5.1419-1426.1989. View

Hu X, Chen S, Li J, Yu D, Yi-Zhang , Cai H . An IL-15 adjuvant enhances the efficacy of a combined DNA vaccine against Brucella by increasing the CD8+ cytotoxic T cell response. Vaccine. 2010; 28(12):2408-15. DOI: 10.1016/j.vaccine.2009.12.076. View

10.

Uza F, Samartino L, SCHURIG G, Carrasco A, Nielsen K, Cabrera R . Effect of vaccination with Brucella abortus strain RB51 on heifers and pregnant cattle. Vet Res Commun. 2000; 24(3):143-51. DOI: 10.1023/a:1006468713614. View

11.

Jain-Gupta N, Contreras-Rodriguez A, Vemulapalli R, Witonsky S, Boyle S, Sriranganathan N . Pluronic P85 enhances the efficacy of outer membrane vesicles as a subunit vaccine against Brucella melitensis challenge in mice. FEMS Immunol Med Microbiol. 2012; 66(3):436-44. PMC: 4426994. DOI: 10.1111/1574-695X.12010. View

12.

Moriyon I, Grillo M, Monreal D, Gonzalez D, Marin C, Lopez-Goni I . Rough vaccines in animal brucellosis: structural and genetic basis and present status. Vet Res. 2004; 35(1):1-38. DOI: 10.1051/vetres:2003037. View

13.

Yu D, Hu X, Cai H . A combined DNA vaccine encoding BCSP31, SOD, and L7/L12 confers high protection against Brucella abortus 2308 by inducing specific CTL responses. DNA Cell Biol. 2007; 26(6):435-43. DOI: 10.1089/dna.2006.0552. View

14.

Arsenault J, Girard C, Dubreuil P, Belanger D . Lack of evidence of Brucella ovis infection in rams in Quebec. Can Vet J. 2004; 45(4):312-4. PMC: 548616. View

15.

Becker H, Belden R, Breault T, Burridge M, Frankenberger W, Nicoletti P . Brucellosis in feral swine in Florida. J Am Vet Med Assoc. 1978; 173(9):1181-2. View

16.

Rueckert C, Guzman C . Vaccines: from empirical development to rational design. PLoS Pathog. 2012; 8(11):e1003001. PMC: 3493475. DOI: 10.1371/journal.ppat.1003001. View

17.

Dzata G, Confer A, Wyckoff 3rd J . The effects of adjuvants on immune responses in cattle injected with a Brucella abortus soluble antigen. Vet Microbiol. 1991; 29(1):27-48. DOI: 10.1016/0378-1135(91)90108-r. View

18.

Winter A, Rowe G . Comparative immune responses to native cell envelope antigens and the hot sodium dodecyl sulfate insoluble fraction (PG) of Brucella abortus in cattle and mice. Vet Immunol Immunopathol. 1988; 18(2):149-63. DOI: 10.1016/0165-2427(88)90057-8. View

19.

Banai M . Control of small ruminant brucellosis by use of Brucella melitensis Rev.1 vaccine: laboratory aspects and field observations. Vet Microbiol. 2002; 90(1-4):497-519. DOI: 10.1016/s0378-1135(02)00231-6. View

20.

Amano A, Takeuchi H, Furuta N . Outer membrane vesicles function as offensive weapons in host-parasite interactions. Microbes Infect. 2010; 12(11):791-8. DOI: 10.1016/j.micinf.2010.05.008. View